Best GLP-1 Supplements of 2026

Pasteurised Akkermansia muciniphila MucT — the exact strain in the exact form the published human trials used. Everything else in this segment is an interpretation of that research; this is the research.

• +The specific strain and heat-treated form from the Belgian pilot trial, not an approximation of it
• +Pasteurisation removes the stomach-acid survival problem that undermines live competitors
• +150 mg per capsule with cell count disclosed — a single studied ingredient, no blend
• +Makes no GLP-1 claim at all despite holding the strongest position in the category to make one
• -Pricing is published inconsistently across channels, there is no prebiotic to support the organism, and trial weight change was modest — a few pounds.

The only product here that correctly identifies what a supplement can do for someone on a GLP-1 — cover the nutrient gaps that open up when you eat far less — and does not pretend to do anything else.

• +Addresses a genuine, documented problem rather than an invented one
• +USP-verified, which is meaningful in a category with no pre-market testing requirement
• +Makes no claim about raising GLP-1, curbing cravings or causing weight loss
• +Designed as a companion to prescription treatment, not a replacement for it
• -It is a multivitamin pack. If you wanted a gut or metabolic intervention, this is not that — and it is not trying to be.

The same three strains as our top pick, from the company that solved commercial anaerobic manufacturing first — at close to three times the daily cost, with nothing to feed them.

• +Akkermansia, Clostridium butyricum and Bifidobacterium infantis, each named individually
• +Best-in-category anaerobic manufacturing — genuinely difficult and Pendulum did it first
• +Delayed-release delivery appropriate to live anaerobes
• +Two companies converging on this strain trio suggests the reasoning is sound
• -$65 against $23.83 for the same strains with prebiotics added, no prebiotic component of its own, and a craving claim its own evidence does not support.

Ignores the GLP-1 mimicry story entirely and targets lean mass loss — documented at roughly 40% to 60% of total weight lost — with 20 g of whey plus myHMB.

• +Addresses the best-documented problem in GLP-1 treatment rather than a claimed one
• +myHMB is a branded leucine metabolite with real muscle preservation research
• +Calcium and vitamin D target the bone density concern that travels with rapid weight loss
• +'GLP-1 Support' here honestly means support for people taking one, not a claim to replicate it
• -Only 12 servings per tub at about $3.33 a serving, and the sunflower creamer brings corn syrup solids and sodium caseinate.

Delivers resistant starch in grams rather than milligrams, which puts it in the range the fibre research actually studied — the single most common failure elsewhere in this category.

• +Meaningful resistant starch dose from unripened green banana, not a token capsule amount
• +Fibre has the strongest mechanistic evidence of anything in this category
• +Powder format makes a real dose practical where capsules cannot
• +Among the cheapest per serving on this list
• -Fermentable fibre causes gas and bloating if you ramp up quickly. Increase gradually and drink more water than feels necessary.

Two branded, human-trialled fibres from a company that serves bariatric surgery patients rather than the wellness market — and it shows in the tolerability engineering.

• +Solnul resistant potato starch and Sunfiber both named on the label with published trial data
• +Partially hydrolysed guar gum ferments far more gently than the inulin competitors use
• +Powder format delivers fibre at a dose where the mechanism actually operates
• +Third-party tested
• -20 servings per container rather than 30, so a real month is nearer $40 — and the DPP-IV inhibition claim reaches for the mechanism of prescription gliptins without the evidence.

The cheapest way to buy the pasteurised form the trial data actually supports, with a label that uses the correct terminology and claims nothing it cannot back.

• +Pasteurised form performed at least as well as live in the pilot trial
• +No survival problem means no expensive delayed-release engineering to pay for
• +Quoted in TFU rather than a misleading CFU figure — the correct unit for non-viable cells
• +$25 against $54–$96 for the premium Akkermansia options
• -1 billion TFU is a lower count than several competitors quote, and it does not publish the MucT strain designation.

The only product in this set with a clinical trial on the finished formula rather than on its ingredients — and it refuses to make a GLP-1 claim at all.

• +Trial data on the finished product, not extrapolated from ingredient research
• +24 characterised strains at a disclosed 53.6 billion AFU
• +Capsule-in-capsule design engineered specifically for stomach acid survival
• +Addresses the digestive side effects that cause people to quit GLP-1 treatment
• -Contains no Akkermansia, is not positioned for this category at all, and $49.99 a month is premium.

Physician-formulated around the actual reason people abandon GLP-1 treatment — side effects — with vitamin B6, which has a genuine nausea evidence base.

• +B6 has real nausea evidence, most firmly established in pregnancy
• +Targets the side effects that cause people to stop treatment rather than inventing a mechanism
• +Magnesium does double duty for constipation
• +Created by a physician practising in obesity medicine
• -$34.99 is expensive for an electrolyte mix — LMNT delivers considerably more sodium for roughly $1.50 a serving.

Notices that patients are told to eat more protein while the medication is actively slowing their gastric emptying, and adds papain and bromelain to bridge the conflict.

• +Correctly identifies a real conflict between standard advice and the drug's mechanism
• +Proteolytic enzymes are a sensible response to delayed gastric emptying
• +Addresses lean mass loss, the best-documented GLP-1 nutrition concern
• +Liquid protein is easier to consume on a suppressed appetite
• -$45 buys less protein per dollar than a plain whey isolate, the enzyme evidence at these doses is thin, and there is no HMB.

Every amount printed with source compounds named, 1,000 mg of sodium a stick, and no claim beyond hydration — the value benchmark this category is measured against.

• +Fully disclosed amounts with source compounds named — exemplary labelling
• +1,000 mg sodium decisively addresses the most common deficit when intake drops
• +Far more electrolyte per dollar than any GLP-1-branded alternative
• +Makes no GLP-1, appetite or weight loss claim whatsoever
• -A gram of sodium per serving is genuinely a lot — not for anyone advised to restrict sodium — and there is no B6 for nausea.

The company that made Akkermansia commercially available, with the manufacturing capability and delayed-release delivery that anaerobic strains genuinely require.

• +Serious anaerobic manufacturing capability — this is genuinely difficult to do at scale
• +Delayed-release delivery appropriate to the strain
• +Single named strain rather than a blend, so you know exactly what you are buying
• +The closest thing in this category to a research-aligned product
• -Expensive for a single strain, with no prebiotic component to feed it once it arrives.

Contains tributyrin — a butyrate precursor targeting exactly the pathway this whole category invokes — and pointedly declines to market itself as a GLP-1 product. That restraint is instructive.

• +LGG and BB-12 are among the most extensively studied probiotic strains in existence
• +PreforPro label dose of 15 mg matches the dose used in human trials — almost nothing here does that
• +Industry-leading supply chain and sourcing transparency
• +Makes no GLP-1 or weight loss claim it cannot support
• -No Akkermansia, no meaningful fibre dose, and nothing here addresses appetite — which Ritual is upfront about.

A fibre-forward product from a brand with real formulation standards, aimed at the bloating and digestive discomfort that fibre genuinely helps with.

• +Prebiotic fibre in a format that permits a real dose
• +Third-party tested, which is one of the few meaningful quality signals available here
• +Targets digestive comfort — an outcome fibre actually delivers
• +Established brand with genuine customer service infrastructure
• -The 'GLP-1 Booster' name promises more than fibre alone delivers, even though the fibre itself is sound.

Akkermansia alongside Clostridium butyricum at roughly half the price of the premium single-strain options, with the strains named rather than blended.

• +Named strains including Akkermansia and Clostridium butyricum
• +$29.99 undercuts most of the Akkermansia segment substantially
• +Butyrate-producing strain adds a mechanistically sensible second component
• +Widely available rather than direct-only
• -Less delivery detail published than the premium options, which matters more for anaerobes than for most probiotics.

The research-grade pasteurised MucT strain at a disclosed 30 billion per tablet, surrounded by ingredients that add cost without earning their place.

• +Same research-grade pasteurised MucT strain as Akkermansia Essential
• +30 billion bacteria per tablet, disclosed rather than vague
• +EGCG has some published GLP-1 mechanistic support
• -Chromium has consistently disappointing evidence, 'dual action' overstates what EGCG and chromium jointly deliver, and the plain Essential product is the better buy for most people.

A practitioner-channel product with the quality standards that channel implies, priced accordingly and aimed at people working with a clinician.

• +Professional-use manufacturing standards
• +Named strain with clear specification
• +Sold through practitioners, which brings clinical oversight with it
• +Formulation quality is genuinely high
• -$95.99 is the highest price on this list, and the formulation advantage over cheaper Akkermansia products does not obviously scale with it.

Correctly pairs the organism with chicory inulin so it has something to ferment, widely stocked so you can compare prices — with one number that needs explaining.

• +Pairs Akkermansia with chicory inulin rather than delivering it alone
• +90-capsule bottle works out to about $23.33 a month
• +Stocked at Target, Amazon and iHerb, so pricing is easy to verify
• +Shelf-stable, gluten-free and non-GMO
• -100 million AFU sits roughly 300-fold below the research-grade pasteurised products' disclosed counts, and nothing on the label reconciles the gap.

A mass-market vitamin brand with no influencer narrative to protect, printing berberine at 425 mg on the label and keeping its claims unusually close to the evidence.

• +Berberine disclosed at 425 mg — a meaningful, checkable dose
• +About $0.86 a serving, roughly half what comparable products charge
• +Decaffeinated green tea avoids the sleep disruption that worsens food noise
• +Frames itself as supporting diet and exercise rather than replacing them
• -Chromium's 571% Daily Value is impressive-looking and evidentially weak, no third-party testing is advertised, and the GLP-1 name still oversells the formula.

A thoughtful HMO prebiotic pairing and a format that solves a real accessibility problem — wrapped around a delivery method that works against the headline organism.

• +Human milk oligosaccharides have credible gut barrier research and pair sensibly with Akkermansia
• +Chewable format is genuinely useful for people who cannot manage capsules
• +Combines the organism with prebiotics to feed it
• -A chewable cannot carry delayed-release protection an anaerobe needs, collagen and resveratrol add little, amounts are undisclosed, and $74.99 is roughly three times better-specified alternatives.

Publishes amounts and standardisation ratios competitors bury in blends, and is unusually honest that results take six months alongside diet and exercise.

• +Discloses amounts and extract ratios most of this category hides
• +Ceylon cinnamon rather than cassia — the safer choice for sustained use
• +Curcumin C3 Complex and AXIVITE are branded ingredients with real research programmes
• -Three capsules a day is a genuine adherence problem, the 90-count bottle is only a 30-day supply, and boron and aloe vera are hard to justify at all.

Two standardised botanicals and clean disclosure, attached to the strongest mechanistic claim in this category — one the underlying pharmacology does not support.

• +Only two actives, both standardised and disclosed, in a category of opaque blends
• +A genuine 30-day supply at an honest $1.00 per day
• +Xanthohumol and beta-caryophyllene are real compounds with real literature
• -'Activates GLP-1 receptors' does not hold — beta-caryophyllene is a CB2 agonist, a different receptor in a different family — and the evidence is preclinical rather than human outcome data.

A competently built, stimulant-free berberine product from a sports nutrition manufacturer — held back by the ceiling on what berberine does rather than by how it is made.

• +Enhanced-absorption berberine addresses a real bioavailability problem
• +Stimulant free, which matters because poor sleep reliably worsens food noise
• +Established manufacturer with genuine production standards
• +Green tea extract has some published mechanistic support
• -Berberine averages about 4.5 lbs over eight weeks or more, carries real drug interaction potential, and chromium picolinate has disappointed repeatedly.

Combines berberine with probiotics in a formula that is not unreasonable on paper, wrapped in marketing that consistently outruns what the ingredients support.

• +Berberine plus probiotic is a coherent combination in principle
• +Direct-to-consumer brand with established fulfilment
• +Some named ingredients rather than a wholly opaque blend
• -Claims run well ahead of the evidence, dose disclosure is limited, and direct-only pricing makes comparison harder than it should be.

Genuinely easier to take when nauseated, and choosing Ceylon cinnamon over cassia is a real quality decision — undermined by arithmetic the label does not address.

• +Berberine disclosed at 500 mg, within the studied range
• +Ceylon rather than cassia cinnamon avoids coumarin liver concerns
• +Liquid format genuinely helps people who cannot manage capsules
• -A 2 fl oz bottle at 60 servings is roughly 1 ml a dose — fitting 500 mg plus eight more actives into that is not credible, and only the berberine amount is disclosed.

The most mechanically persuasive appetite fibre in the category, and the one where a randomised trial actually looked and found nothing.

• +Genuinely effective as a bulk-forming fibre for regularity
• +Very cheap, from a large manufacturer with real quality control
• +No inflated GLP-1 branding or mechanism story attached
• -A randomised trial over eight weeks found no effect on weight, body composition, hunger or fullness — and glucomannan capsules taken without enough water have caused oesophageal obstruction.

Morosil red orange extract is a genuine named ingredient with published research, but at roughly $90 a month you are paying three times what a better-specified formula costs.

• +Morosil is a named branded ingredient with real published work behind it
• +Large consumer review base at 4.3 stars across 1,000+ reviews
• +Independently reviewed by registered dietitians, which aids scrutiny
• -About $90 a month with no strain specificity, no meaningful fibre dose and fat loss claims that outrun the evidence. At this price the opportunity cost against actual treatment becomes the main argument.

Three defensible ingredients paired with two of the most thoroughly discredited weight loss compounds of the past twenty years, at undisclosed doses, from no consistent manufacturer.

• +Berberine, cinnamon and turmeric are defensible inclusions in principle
• +Sugar-free, and a workable format for people who cannot swallow capsules
• -Garcinia cambogia carries documented liver injury case reports, raspberry ketones have no credible human evidence, no amounts are disclosed, and near-identical listings appear under multiple sellers with no accountable manufacturer.

The only entry here we would advise against at any price — not because the evidence is weak, but because the delivery route physically cannot carry the ingredients claimed.

• +Convenient to apply, if convenience were the relevant question
• -No human trials show OTC patches raise GLP-1 secretion, there is no FDA approval or quality regulation, and transdermal delivery cannot carry hundreds of milligrams of berberine or plant extracts. The real cost is delayed treatment.